PerkinElmer subsidiary Euroimmun has launched a SARS-CoV-2 antigen enzyme-linked immunosorbent (ELISA) assay that can detect the proteins from the virus.
The laboratory test, which has received the CE Mark, can be applied in semiquantitative automatable detection of the SARS-CoV-2 nucleocapsid protein on a large scale. It is validated from swab samples taken from the upper respiratory tract, and it has a 93.6% sensitivity and 100% specificity, according to the vendor.